Conservative Treatment of Esotropia in Children up to 3 Years Old
NCT ID: NCT02404324
Last Updated: 2017-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2012-01-31
2017-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Prospective Observational Study of Adult Strabismus
NCT02510040
Bifocal Spectacles vs. Single Vision Spectacles for Esotropia Greater at Near
NCT05527015
Study of Non-surgical Treatment Versus Observation in Asian Children With Intermittent Exotropia
NCT01267500
Observational Study of Optical Correction for Strabismic Amblyopia in Children 3 to <7 Years Old
NCT00669539
Study of Surgical Treatment Versus Observation in Children With Moderate Intermittent Exotropia
NCT02736526
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
spectacles
Esotropia is treated by full optical correction (spectacles prescription) in all children with refractive errors. Special attention is paid to astigmatism up to 0.5 Dptr.
Intervention: Prescription of spectacles
Prescription of spectacles
All children are prescribed full optical correction of refractive errors with special attention to astigmatism up to 0.5 Dptr to achieve maximal clear image on the retina of both eyes.If necessary, direct occlusion or penalization are administered to the children.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prescription of spectacles
All children are prescribed full optical correction of refractive errors with special attention to astigmatism up to 0.5 Dptr to achieve maximal clear image on the retina of both eyes.If necessary, direct occlusion or penalization are administered to the children.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with constant or periodic esotropia and with revealed angle of deviation 5 degrees or over by Hirschberg test
* Patients with refractive errors (inclusive minor ametropias from 0.5 Dptr)
Exclusion Criteria
* Patients with neurological diseases and paralytic strabismus
3 Months
3 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Centre of Ophthalmology named after academician Zarifa Aliyeva
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elmar Kasimov, Professor
Role: STUDY_DIRECTOR
National Centre of Ophthalmology named after academician Zarifa Aliyeva
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Treatment of Esotropia
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.